Chris has an extensive background in the commercialization of innovation in the private sector, academic sector, and at private research institutions. During his 35-year career, he has served as a venture capitalist, board leader, inventor, entrepreneur, licensing executive, and national government innovation program director, and has participated in all the core pillars of innovation commercialization. Most recently, Chris served as Senior Vice President of New Ventures at Xinova, a global innovation network that represents more than 100 research institutes, universities and companies and over 10,000 inventors that conduct industry, technology and competitive analysis to develop commercialization strategies for novel innovations and inventions.
Chris has been the founder of numerous companies, as well as a venture capital partner and angel investor in many others, in diversified fields that include medtech, biotech, photonics, optical logic, semiconductors, food/ag and manufacturing. Earlier in his career, he served as GM of the New Zealand government’s $500 million innovation grant system that provided grants for innovative R&D, STEM student internships, accelerator programs, and technology start up incubators across New Zealand, and as Senior Strategist for Intellectual Ventures where he managed over $600 million in intellectual property creation funds. He is also a pioneer in tissue engineering, having founded, led, and sold Dentigenix to Europe’s leading dental company within 18 months from inception. Chris has a MS in Biomedical Engineering from Tulane, an MBA from the University of Washington, and a BSE in Biomedical Engineering from Purdue.